Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥6.01 |
52 Week High | CN¥6.93 |
52 Week Low | CN¥3.43 |
Beta | 0.049 |
11 Month Change | 23.16% |
3 Month Change | 11.71% |
1 Year Change | 12.55% |
33 Year Change | -36.80% |
5 Year Change | 46.59% |
Change since IPO | 104.77% |
Recent News & Updates
Recent updates
Shareholder Returns
300318 | CN Medical Equipment | CN Market | |
---|---|---|---|
7D | 19.7% | -0.8% | -0.3% |
1Y | 12.5% | -14.6% | -18.1% |
Return vs Industry: 300318 exceeded the CN Medical Equipment industry which returned -16.2% over the past year.
Return vs Market: 300318 exceeded the CN Market which returned -19% over the past year.
Price Volatility
300318 volatility | |
---|---|
300318 Average Weekly Movement | 6.0% |
Medical Equipment Industry Average Movement | 5.1% |
Market Average Movement | 5.6% |
10% most volatile stocks in CN Market | 8.9% |
10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 300318 has not had significant price volatility in the past 3 months.
Volatility Over Time: 300318's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2001 | 1,961 | Zhiwei Shen | www.bohui-tech.com |
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and after-sale service of diagnostic products in China. It offers GenPlex, a microfluidic automated nucleic acid detection system, immunofluorescence detection products, and human trace element detection products; and chemical analysis products, such as atomic fluorescence; mass spectrometry and separation analysis, life sciences related consumables, and ICP spectroscopy.
Beijing Bohui Innovation Biotechnology Group Co., Ltd. Fundamentals Summary
300318 fundamental statistics | |
---|---|
Market cap | CN¥4.91b |
Earnings (TTM) | -CN¥10.24m |
Revenue (TTM) | CN¥1.05b |
4.7x
P/S Ratio-479.5x
P/E RatioIs 300318 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
300318 income statement (TTM) | |
---|---|
Revenue | CN¥1.05b |
Cost of Revenue | CN¥561.96m |
Gross Profit | CN¥492.56m |
Other Expenses | CN¥502.80m |
Earnings | -CN¥10.24m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 30, 2024
Earnings per share (EPS) | -0.013 |
Gross Margin | 46.71% |
Net Profit Margin | -0.97% |
Debt/Equity Ratio | 38.1% |
How did 300318 perform over the long term?
See historical performance and comparison